Search results

4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.

ACBio delivers marketing & communications strategies, content, and brand narratives to life science companies worldwide to help them gain market leadership. We blend PhD-level scientific knowledge with effective marketing tactics to translate complex tech into understandable value for stakeholders.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

APR Applied Pharma Research s.a. (wholly owned by Relief Therapeutics Holding AG, SIX: RLF.SW), is a B2B Swiss-based international biopharma focused on development and global commercialization of innovative, patent protected products designed to address unmet needs.

BigOmics Analytics is a Swiss bioinformatics company accelerating omics data analysis for precision medicine. Its cloud-native platform, Omics Playground, empowers researchers to visualize, interpret and share complex omics data fostering efficient collaboration.

Bromatech has been engaged for more than 25 years in the study and development of targeted food supplements based on specific strains of lactic acid bacteria, antioxidants and essential fatty acids which are able to interact with the precious heritage of the human microbiota.

With over 40 years in the pharmaceutical industry, Cerbios is a privately held company headquartered in Barbengo‑Lugano, Switzerland, specialising in the development and manufacture of both chemical and biological APIs for its partners worldwide.

Chelonia collaborates with industry, academia, and public institutions to accelerate R&D, commercialize innovations, and secure funding. We offer strategic partnerships, expert guidance, and project support to maximize impact.

We are an independent biotech company based in Ticino. We focus on generation, development and characterization of nanobodies produced from proprietary, rationally engineered human libraries relevant to enhance the R&D pipeline of partners and clients.

CROss Alliance® is a Swiss CRO specialised in early clinical development. With more than 500 trials performed at CROSS phase I unit or in selected EU sites, we are experts in PK, bioequivalence, first in man, tolerability studies including cardiac safety and efficacy models in healthy volunteers.

Devintec Pharma is focused on B2B partnerships through out-licensing innovative substance-based medical devices. We apply DevinPro™ technology, that addresses root causes and creates a protective barrier for lasting relief, to our patended products in gastroenterology, dermatology, and gynecology.

DIAMANTE is a boutique business and management consulting company dedicated to biotech and pharma clients, diagnostics companies and investors in healthcare. We support companies to streamline product design and development, and work with investors to accelerate and de-risk their selected assets.

Ectica Technologies supplies hydrogel-based tools to the biopharmaceutical and life science industries for drug discovery and bioresearch applications. Ectica Technologies manufactures and supplies the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. It en

Clinical-stage biotech company developing next-generation allosteric therapies. Its candidate, GT-02287, is in P1b trials for PD with potential in other neurodegenerative and lysosomal storage disorders. The pipeline also includes preclinical programs targeting metabolic diseases and solid tumors.

Healiva’s Wound Care & Skin Diseases proprietary Platform Technology includes an end-to-end approach with enzyme technology and cell therapies for wound care and skin diseases. The platform can diversify into vitiligo management, skin regeneration or sports injury applications.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology.

Holding, management consulting & strategy advisory focused on biotech, medtech, nutraceuticals and health services. Our strong knowledge of international competitive and synergistic landscape and our large network of strategic partners help our clients to expand into new jurisdictions and markets.

InVirtuoLabs is pioneering the next-generation laboratory by integrating AI with molecular simulations to revolutionize drug discovery. Our platform generates up to 1 billion novel molecules per day, rapidly screening and identifying the most promising ligands for specific biological targets.

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricate novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).

Our mission is to propel healthcare forward by investing in solutions that promise to enhance global well-being, driven by a team whose core strengths lie in strategic investment, scientific analysis, and an acute understanding of healthcare market dynamics.

Business Strategy and Development Partner in the Life Science Industry with over 30 years of experience in Pharma, Pharma Chemistry and Biotech.  

Microsphere (MS) is a CDMO focused on new developments, cGMP manufacturing, R&D, analytical and regulatory support. MS is able to address complex challenges, including formulations for poorly water-soluble drugs, considering the extensive expertise in Spray Drying and Capsule Filling.

MicThera harnesses microbes to discover breakthrough therapeutics, leveraging microbial bioactive molecules -synthetically produced- to overcome therapy resistance. Our discovery platform unlocks microbial-inspired therapeutics to develop innovative treatments.

A Swiss microbiota biotherapeutics and mucosal vaccines company with two technology platforms: ApyraVax for the generation of innovative mucosal vaccines; ApyraMed with indications in IBD, dysbiosis induced by antibiotic treatments and unhealthy diet, and as enhancer in cancer immunotherapy.

Streamlining complexity: with 15+ years experience (EU, US and Far East) in Oncology, Rare Diseases and Quality of Life Assessment, Naexture provides ad-interim leadership roles in Clinical Operations and Program Management to end-to-end operationalize clinical research programs.

Oculox Technologies is a medical device company focused on the application of state-of-the art micro and laser technology in the field of medical diagnostics and therapy.

Oriento means “to orientate”, to show the right way to someone that is looking for something. With decades of experience in the life science sector, we are prepared to share our real life learnings with our clients advising them on the best pathway to get a successful result.

Founded in 2018, Peptone specializes in novel therapeutics for Intrinsically Disordered Proteins (IDPs), linked to inflammatory diseases such as cancer. Their approach integrates biophysics, supercomputing, and machine learning, now advancing in their labs.

We develop complex dosage forms enabling early market entry generic drugs and innovative supergeneric products. We deal with licensing-out to leading Pharma partners worldwide for market access.

Schedio delivers high-containment isolators for safe HPAPI and ADC handling. Our spray drying solutions ensure precise particle control for stable ADCs. With tailored support, we optimize bioavailability and foster long-term partnerships.

Sferalp is specialized in the formulation of Self Emulsifying Oils (SEFO) containing extracts or API. SEFO maximize gastro-intestinal absorption. We have developed a SEFO based on natural food components (Patent pending). We provide development in the field of electro- and conventional spray drying.

SPILLO supports pharmaceutical and biotech R&D teams through unbiased, in silico, proteome-wide identification of targets and off-targets. Using exclusive, experimentally validated, physics-based computational technology, SPILLO reduces scientific risk and clarifies mechanisms in drug development.

TissueLabs is a Swiss biotech pioneering biofabrication, developing 3D bioprinters, tissue-specific hydrogels, and engineered tissues. Supporting research, drug testing, and regenerative medicine, its long-term vision is to create the first transplantable bioartificial heart.

Zambon Biotech is part of the Zambon group, it is focused in growing the portfolio and pipeline of the Zambon group by entering into partnerships, acquiring assets and supporting their clinical development up to commercialization as well as licensing commercial stage assets.